Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

SANA Sana Biotechnology Inc

4,75

0,00 (0,00%)

15 Aug 2024 - Geschlossen

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Sana Biotechnology (NASDAQ:SANA)
Historical Stock Chart
Von Jul 2024 bis Aug 2024

Click Here for more Sana Biotechnology Charts.

Sana Biotechnology (NASDAQ:SANA)
Historical Stock Chart
Von Aug 2023 bis Aug 2024

Click Here for more Sana Biotechnology Charts.

News Sana Biotechnology Inc

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 8 August 2024 (6 Tage vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 8 August 2024 (6 Tage vor) • Edgar (US Regulatory)

Sana Biotechnology Reports Second Quarter 2024 Financial Results and Business Updates
Donnerstag 8 August 2024 (6 Tage vor) • GlobeNewswire Inc.

Flagship Pioneering Announces Appointment of Raj Panjabi as Senior Partner
Dienstag 6 August 2024 (1 Woche vor) • PR Newswire (US)

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Montag 15 Juli 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 7 Juni 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 7 Juni 2024 (2 Monate vor) • Edgar (US Regulatory)

Sana Biotechnology Highlights Publication in Nature Biotechnology of Novel In Vivo Preclinical Data Showing the Potential for Pluripotent Stem Cell-Derived Human Glial Progenitor Cell Transplantation as a Treatment for Huntington’s Disease and Other Glia
Dienstag 21 Mai 2024 (3 Monate vor) • GlobeNewswire Inc.

Form S-8 - Securities to be offered to employees in employee benefit plans
Mittwoch 8 Mai 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 8 Mai 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 8 Mai 2024 (3 Monate vor) • Edgar (US Regulatory)

Sana Biotechnology Reports First Quarter 2024 Financial Results and Business Updates
Mittwoch 8 Mai 2024 (3 Monate vor) • GlobeNewswire Inc.

Weitere Sana Biotechnology Inc News-Artikel

Gold vs US Dollar

JP Morgan Chase

Euro vs Sterling

Deutsche Lufthansa

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen